demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 severe or critically
COVID-19 severe or critically
baricitinib COV-BARRIER ...

1 studies excluded by filtering options 0

9239 Tziolos, 2021 1130not a RCTrisk of bias not avaialble